Literature DB >> 25437971

Quality-of-life impairment in patients with livedoid vasculopathy.

Maria Rita Polo Gascón1, Jozélio Freire de Carvalho2, Danielle Priscila de Souza Espinel1, Alessandra Moraes Barros1, Afsaneh Alavi3, Paulo Ricardo Criado1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25437971     DOI： 10.1016/j.jaad.2014.06.030

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  3 in total

Review 1.  Efficacy and safety of intravenous immunoglobulin for treating refractory livedoid vasculopathy: a systematic review.

Authors:  Yimeng Gao; Hongzhong Jin
Journal:  Ther Adv Chronic Dis       Date:  2022-05-22       Impact factor: 4.970

2.  Intravenous Immunoglobulin Therapy in Livedoid Vasculopathy: Retrospective Observation of Clinical Outcome and Patient's Activity Level.

Authors:  Katrin Kofler; Anke Strölin; Vanessa Geiger; Lukas Kofler
Journal:  J Cutan Med Surg       Date:  2021-03-28       Impact factor: 2.092

3.  Livedoid vasculopathy - A diagnostic and therapeutic challenge.

Authors:  Maria Rosa Burg; Carolin Mitschang; Tobias Goerge; Stefan Werner Schneider
Journal:  Front Med (Lausanne)       Date:  2022-10-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.